StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by RelevantStockon Aug 17, 2020 8:17pm

196 Views

Post# 31420544

RE:College Student and Airline Employee COVID Testing

Depending on how well they they tie links to airlines and other large essential services, SZLS could reach the level of SONA in a year, my personal opinion. On the difference of the other covid stocks, they will generate massive revenue.

If they scale up to a capacity of 3000 tests / day and keep the results delivered under 3 days, revenues could grow again very quickly.

Bullboard Posts

5 steps to mastering risk management in the stock market